A Phase I Study of High-dose BCNU, Etoposide and Escalating-dose Thiotepa (BTE) with Hematopoietic Progenitor Cell Support in Adults with Recurrent and High-risk Brain Tumors

[1]  J. Bruce,et al.  High-dose thiotepa and etoposide-based regimens with autologous hematopoietic support for high-risk or recurrent CNS tumors in children and adults , 1998, Bone Marrow Transplantation.

[2]  D. Heitjan,et al.  Harvest quality and factors affecting collection and engraftment of CD34+ cells in patients with breast cancer scheduled for high-dose chemotherapy and peripheral blood progenitor cell support. , 1997, Journal of hematotherapy.

[3]  M. Sanson,et al.  Treatment of recurrent malignant supratentorial gliomas with ifosfamide, carboplatin and etoposide: a phase II study. , 1996, European journal of cancer.

[4]  R. Zimmerman,et al.  Pilot study of high-dose thiotepa and etoposide with autologous bone marrow rescue in children and young adults with recurrent CNS tumors. The Children's Cancer Group. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  G. Calais,et al.  High-dose BCNU with ABMT followed by radiation therapy in the treatment of supratentorial glioblastoma multiforme. , 1996, Bone marrow transplantation.

[6]  J. Shuster,et al.  High-dose melphalan and cyclophosphamide with autologous bone marrow rescue for recurrent/progressive malignant brain tumors in children: a pilot pediatric oncology group study. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  P. Graham.  Meta‐analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults , 1993, Cancer.

[8]  R. Krance,et al.  High-dose chemotherapy and autologous bone marrow rescue followed by interstitial and external-beam radiotherapy in newly diagnosed pediatric malignant gliomas. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  H. Fine,et al.  Meta‐analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults , 1993, Cancer.

[10]  H. Fine,et al.  High-dose chemotherapy with autologous bone marrow transplantation in the treatment of high grade astrocytomas in adults: therapeutic rationale and clinical experience. , 1992, Bone marrow transplantation.

[11]  G. Vassal,et al.  High-dose busulfan and thiotepa with autologous bone marrow transplantation in childhood malignant brain tumors: a phase II study. , 1992, Bone marrow transplantation.

[12]  J. Fay,et al.  High-dose N,N',N"-triethylenethiophosphoramide (thiotepa) with autologous bone marrow transplantation: phase I studies. , 1990, Seminars in oncology.

[13]  Audrey E. Evans,et al.  The effectiveness of chemotherapy for treatment of high grade astrocytoma in children: Results of a randomized trial , 1989, Journal of Neuro-Oncology.

[14]  J. Fay,et al.  Intensive 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU) monochemotherapy and autologous marrow transplantation for malignant glioma. , 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  L. Parker,et al.  Autologous bone-marrow transplantation: host effects of high-dose BCNU. , 1983, Journal of Clinical Oncology.

[16]  W. Mason,et al.  Intensive chemotherapy and bone marrow rescue for young children with newly diagnosed malignant brain tumors. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  C. Mottolese,et al.  Etoposide and thiotepa followed by ABMT (autologous bone marrow transplantation) in children and young adults with high-grade gliomas. , 1997, European journal of cancer.

[18]  J. Graham-Pole,et al.  High-dose chemotherapy with marrow reinfusion and hyperfractionated irradiation for children with high-risk brain tumors. , 1994, Medical and pediatric oncology.